AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05440058 — intervention group
Intervention type: DEVICE
Intervention: Bispectral Index (BIS) monitoring system
Description: Left and right sensors to record EEG activity and muscle reaction to anesthesia utilized in the operating room by anesthesia providers to assess the depth of sedation in patients with anesthesia.
Study NCT05136794 — intervention group
Intervention type: OTHER
Intervention: Data collection
Description: complications: cardiac, neurological, renal, respiratory, red blood transfusion Hospital stays: ICU stays and hospital stay
Study NCT06597266 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Smart template - designed prosthetic check socket
Description: Evidence-generated trial prosthetic sockets are designed automatically by performing machine learning analysis of past socket designs that were produced by expert clinicians, the participant's residual limb size and shape descriptors and patient descriptors
Study NCT06597266 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Clinician-designed prosthetic check socket
Description: Active comparator prosthetic sockets are designed by expert prosthetists, bespoke to the participant, in a computer aided design environment (CAD)
Study NCT06596954 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: lymphocyte-sparing radiotherapy
Description: the radiotherapy regimen is 41.4Gy/23Fx. Ensure 95% coverage of the PTV (Planning Target Volume) and limit the doses to the heart, bilateral lungs, and spinal cord to meet the required dose constraints. While maintaining target coverage and traditional OAR (Organs At Risk) dose constraints, also address dose for lymphocyte-relate organs including the TVB1-12 thoracic vertebral bodies, ribs, spleen, and major thoracic blood vessels.
Study NCT06596954 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: conventional radiotherapy
Description: the radiotherapy regimen is 41.4Gy/23Fx. Ensure 95% coverage of the PTV (Planning Target Volume) and limit the doses to the heart, bilateral lungs, and spinal cord to meet the required dose constraints. do not limit dose for lymphocyte-relate organs including the TVB1-12 thoracic vertebral bodies, ribs, spleen, and major thoracic blood vessels.
Study NCT06356935 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: RT
Description: Resistance training
Study NCT06356935 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CON
Description: Control group
Study NCT06606184 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle Training
Description: Participants underwent a 12-week program consisting of inspiratory muscle training twice daily, incentive spirometry three times daily, and upper limb exercises along with marching in place for 30 minutes.
Study NCT06606184 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Routine Care
Description: Participants received routine care, which included encouragement to use incentive spirometry three times daily.
Study NCT06605352 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: The BIOFIRE®FILMARRAY® Pneumonia Panel
Description: The BIOFIRE®FILMARRAY® Pneumonia Panel is the only FDA approved mPCR test that can test 18bacteria (11 Gram negative, 4 Gram positive and 3 atypical), 7 antibiotic resistance markers, and 9 viruses in one test within 45 minutes.~Using rapid diagnostic test to improve the proportion of antibiotics change, including escalation, de-escalation, discontinuation, or addition of antimicrobial medications in 24 hours within sample collection.
Study NCT06604780 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Transitional discharge program
Description: For patients classified in the low-risk group, general measures would be applied. For patients in the medium-risk group, reinforced measures would be implemented. Lastly, for patients considered to be in the high-risk group, intensive case management measures would be applied, and if they meet the inclusion criteria, they would be included in the Post-Discharge Group Psychotherapeutic Intervention.~1. General measures~2. Reinforcement measures~3. Intensive measures~   * Intensive case management measures~  * Post-Discharge Psychotherapeutic Recovery Support Program: For application to patients at high risk of early readmission who meet the inclusion criteria. It consists of a multicomponent group psychotherapeutic intervention from a rehabilitative and recovery-oriented perspective. This intervention will be structured into 20 sessions, each lasting 90 minutes, held weekly in an open format.
Study NCT04806854 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LUM-201
Description: Administered orally once daily
Study NCT05001659 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: computer simulator and mannequin simulator
Description: compared two different training simulators with respect to training effectiveness in ACLS training.
Study NCT06608979 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Screening/Referral and Prevention
Description: Session 1: One hour PTSD Screening/referral and Psychoeducation on interpersonal violence (consent, drug-and-alcohol-facilitated assault, intimate partner violence); Session 2: One hour sessions on Protective Behavioral Strategies for interpersonal violence (skills training)
Study NCT06601647 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: adjuvant type
Description: ropivacaine combined with adjuvant
Study NCT06601647 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: adjuvant type
Description: ropivacaine combined with adjuvant
Study NCT06608329 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HDM1002
Description: Single dose, administered orally. The study is a randomized, open-label, single dose, 3-period, 3 sequence, crossover design.
Study NCT06607133 — intervention group
Intervention type: PROCEDURE
Intervention: surgery
Description: patients undergo conventional/open thyroidectomy or endoscopic thyroidectomy for large benign thyroid nodules
Study NCT06607133 — intervention group
Intervention type: PROCEDURE
Intervention: staged thermal ablation
Description: patients undergo multiple sessions of thermal ablation for large benign thyroid nodules
Study NCT06588855 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RO7790121
Description: RO7790121 will be administered as IV infusion. RO7790121 will be administered as SC injection.
Study NCT06588855 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo matching IV RO7790121. Placebo matching SC RO7790121.
Study NCT06609070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CHG0521 Oral Coating
Description: The subjects will receive an oral coating of CHG0521 in the form of drops, in addition to the clinician\&#39;s standard treatment regimen, for a duration of 6 months or until confirmed progression, unacceptable toxicity, or any criteria for withdrawal from the trial.
Study NCT06607042 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychotherapy
Description: Psychotherapy according to the Berlin Dissexuality Therapy (BEDIT)
Study NCT05032690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bosutinib capsule
Description: Bosutinib four 25 mg capsule taken after a high-fat and high calorie breakfast
Study NCT05032690 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bosutinib capsule
Description: Bosutinib 100 mg capsule taken after a high-fat and high calorie breakfast
Study NCT05032690 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bosutinib
Description: Bosutinib 100 mg capsule taken after an overnight fast of at least 10 hours
Study NCT05032690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bosutinib capsule
Description: Bosutinib 100 mg capsule taken after a high-fat and high-calorie breakfast
Study NCT06605898 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MIND Diet
Description: Daily meals designed to increase adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) dietary pattern.
Study NCT06605898 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Diet
Description: Daily meals designed to increase fruit, vegetable, and whole grain intake consistent with a healthy American diet.
Study NCT06352892 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Maridebart Cafraglutide
Description: Solution for SC injection.
Study NCT05707351 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Adynovate
Description: Adynovate will be injected intravenously using an appropriately sized syringe as a bolus infusion over a period of less than or equal to (\<=) 5 minutes (maximum infusion rate, 10 milliliters per minute \[mL/min\]).
Study NCT06699940 — intervention group
Intervention type: DEVICE
Intervention: Transcranial Magnetic Stimulation
Description: Patients between the age of 12-21 received TMS treatment for MDD disorder.
Study NCT06743256 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Surgical System
Description: Levita Magnetic Surgical System
Study NCT06760975 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vestibular Habituation Exercises
Description: The vestibular habituation exercise group follows a structured progression over six weeks. in week 1 participants perform large amplitude, rapid cervical rotations seated, completing 3 sets of five cycles each. By week 2, the exercises increase in complexity , incorporates standing pivots or seated trunk flexion extension. in week 3 the cervical rotations are continued with seated or standing posture. week 4 introduces a busy visual background during the exercise to challenge visual-vestibular integration. In week 5 the exercises are performed standing with the addition complex visual target against a busy background. finally week 6 includes most advance movement including standing pivots 180 degrees and brand-daroff exercises with further visual challenges of near and far targets in busy background. Each exercise session last for 2 minutes and is aimed at progressively enhancing vestibular processing and adaptability.
Study NCT06760975 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ocular Reflex Excercises
Description: The Ocular reflex exercises focuses on enhancing visual tracking and reflexes through targeted viewing exercises. In week 1, participants perform horizontal and vertical X1 viewing exercises with a near target, holding each position for 1 minute while seated. In week 2 the duration of the X1 exercises is extended to 2 minutes with the near target still in seated position. Week 3 shift to a far target for the X1 exercises and the participants performs them while standing increasing the challenge. By week 4 the exercise incorporate both near and far target in front of a busy background. extending the duration to 2 minutes while standing. In week 5 horizontal and vertical X2 viewing exercises are added with a plain background, while still using near and far targets in front of a busy background . finally week 6 continues the X1 and X2 exercises with near and far targets in a busy background, performed for 2 minutes while standing. This aims to improve visual tracking.
Study NCT06761911 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Brentuximab Vedotin (Bv)
Description: 1.2mg/kg/2w or 1.8mg/kg/3w
Study NCT06761911 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sintilimab
Description: 200mg/3w
Study NCT06761911 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tislelizumab
Description: 200mg/3w
Study NCT06761911 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bendamustine
Description: 90mg/m2/3w
Study NCT06761040 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intrinsic foot muscle training
Description: Technique In intrinsic foot muscle training, there are following exercises:~1. Toe spread out~2. First toe extension~3. Second to fifth toe extension The exercise would be performed in following positions 1. Sitting position for the first 2 weeks (3sec hold; 4 sets ×15 reps) 2. Standing position on the 3rd and 4th weeks (8sec hold; 4 sets × 8 reps) 3. One-leg standing position during the 5th and 6th week (20 sec hold;4 sets ×3 reps)
Study NCT04767191 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: artemether lumefantrine
Description: The drugs are approved and in use by the Kenya Ministry of Health as the 1st and 2nd line treatment for malaria. The study is to assess the continued efficacy of the two drugs in the treatment of uncomplicated malaria.
Study NCT04767191 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dihydroartemisinin piperaquine
Description: Antimalarial Combinations
Study NCT05772247 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Lung ultrasound
Description: Lung ultrasound score was calculated by the results of lung ultrasound examination
Study NCT06089200 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transversus Abdominal Plane Block
Description: 20 cc of bupivacaine 0.2% was given to the transversus abdominis plane
Study NCT06089200 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Spinal Morphine
Description: 100 µg was administered intrathecally preoperatively
Study NCT06761040 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intrinsic foot muscle training
Description: Technique In intrinsic foot muscle training, there are following exercises:~1. Toe spread out~2. First toe extension~3. Second to fifth toe extension The exercise would be performed in following positions 1. Sitting position for the first 2 weeks (3sec hold; 4 sets ×15 reps) 2. Standing position on the 3rd and 4th weeks (8sec hold; 4 sets × 8 reps) 3. One-leg standing position during the 5th and 6th week (20 sec hold;4 sets ×3 reps)
Study NCT06761040 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: hip abductor muscle training with intrinsic foot muscle training
Description: Hip abductor muscle training consists of the following two exercise~1. Resisted hip abduction 90° (2 sec hold; 3 sets × 10 reps)~2. Resisted hip abduction 45° (2 sec hold; 3 sets × 10 reps)~Standard treatment~* Shoe insoles (eight hours a day, medial longitudinal arch support,raised for by about 1.8 cm)~* Stretching of Hamstrings and Calf muscles (3 times for 30 seconds hold) Number of Sessions Per Week : 3 times Per week for 6 weeks
Study NCT04720612 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Omalizumab
Description: Single subcutaneous dose of 375mg of omalizumab and standard of care.
Study NCT04720612 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single subcutaneous dose of normal saline in a syringe identical to that of the omalizumab arm and standard of care.
Study NCT06112600 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: VR
Description: Virtual reality glasses were used as a distraction method for children during vaccination.
Study NCT06112600 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Kaleidoscope
Description: Kaleidoscope toys were used as a distraction method for children during vaccination.
Study NCT04652869 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation
Description: Transcranial direct current stimulation targeting the dorsolateral prefrontal cortex
Study NCT06761495 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Baseball Suturing Technique
Description: (Baseball Suturing Technique): A corner suture was placed at the right corner of the incision. Next, the second stitch was placed at the apex of the left corner and tied with a knot. Then, the free end of the suture was cut and running baseball stitch pattern was started. The suturing pattern was performed by taking bites from the inside out through the upper and lower lips of the wound at approximately 1 cm intervals with a 1 cm margin from the wound edges
Study NCT06761495 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Single-Layer Locked Continuous Suturing Technique
Description: (Single-Layer Locked Continuous Suturing Technique): A corner suture was placed at the right corner of the incision. Next, the second stitch was placed at the apex of the left corner and tied with a knot. Then, the free end of the suture was cut and single-layer-locked continuous suturing was started. The suturing pattern was performed by taking bites from outside to inside through the lower lip and inside to outside through the upper lip of the wound. Each time, a lock was formed by passing through the loop formed by the previous suture. The suturing was performed at approximately 1 cm intervals with a 1 cm margin from the wound edges
Study NCT06761495 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Single-Layer Unlocked Continuous Suturing Technique
Description: (Single-Layer Unlocked Continuous Suturing Technique): The uterotomy line was closed in a single-layer continuous suturing pattern that is explained above as group 2 but without passing the needle through the loop formed by the previous sutu
Study NCT06760702 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AUR109 200mg
Description: AUR109 200mg (once daily)
Study NCT06760702 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AUR109 300mg
Description: AUR109 300mg once daily
Study NCT06760702 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AUR109 400mg
Description: AUR109 400mg once daily
Study NCT06760156 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tafasitamab
Description: The recommended dose of tafasitamab is 12 mg/kg.
Study NCT06760156 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: The starting dose for lenalidomide will be 25 mg PO daily.
Study NCT06762678 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: RNA sequencing and whole genome sequencing in a trio way
Description: Patient is not required to be blinded
Study NCT06761807 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Electrophysiology study of heart
Description: The procedure will be done comparatively for each patient; before the device placement and immediately after the procedure.~This will be done approaching the same sheath that is placed for ASD device closure (the right femoral vein).~Only one quadripolar EP catheter will be used, it will be placed in high right atrium then at His bundle.~The EP study will include:~Assessment of SAN function using cSNRT (through HRA pacing) Assessment of AH and HV intervals (through His bundle EGM) Assessment of antegrade AVN RP (refractory period) and AVN WP (Wenckebach point) through extra-stimuli and incremental atrial pacing.~Any inducible arrhythmia will be reported
Study NCT06021158 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Hybrid automated Lyumjev delivery system with carbohydrate counting
Description: In this system, a Lyumjev insulin bolus is initiated at mealtime based on the total grams of carbohydrates counted. This is the same as commercial hybrid closed-loop insulin therapy (standard treatment).
Study NCT06021158 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Hybrid automated Lyumjev delivery system with meal size estimation
Description: In this system, a Lyumjev insulin bolus is initiated at mealtime based on the qualitative amount of carbohydrates estimated (e.g., low-carb meal).
Study NCT06021158 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Fully automated Lyumjev delivery system with meal detection
Description: In this system, the patient does not initiate a Lyumjev insulin bolus at mealtime. An algorithm is used to detect a meal and administer a subsequent bolus, rather than requiring a carbohydrate count.
Study NCT04652869 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness
Description: Mindfulness is a type of meditation in which you focus on being intensely aware of what you're sensing and feeling in the moment, without interpretation or judgment.
Study NCT05757154 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diet
Description: All intervention arms are coffee. Three different types of coffee is tested. Differences in type of bean, degree of roasting and preparation method.
Study NCT05343130 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Brain-Computer Interface
Description: Hand movement will be elicited using functional electrical stimulation activated by the brain-computer interface based on hand movement intention.
Study NCT05343130 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Brain-Computer Interface
Description: Hand movement will be elicited using functional electrical stimulation which activation will be independent of the brain-computer interface based on hand movement intention.
Study NCT06326788 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Short Duration Moderate Intensity Soleus Push-ups
Description: Participants will start soleus pushups in sitting positions. To do so, the participants will be in a seated position, the legs will be at 90 degrees to the floor, and the feet will be placed flat on the ground.~Participants will then move their heels up and down continuously. Soleus push-ups will be performed with moderate intensity using weights which will be placed on their laps.~Participants will perform this activity till 60-70% of their maximum heart rate is achieved and maintained.
Study NCT06036160 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Integrated care
Description: Psychiatric follow-up, cognitive behavioral therapy, physical exercise, psychoeducation